Ledger.Open graph →
SEC Form D · Amendment · filed October 19, 2023

DermBiont, Inc

Offering
$46.8M
Sold
$19.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Daniel R. Yadegar · Boston, MADirectorSteven R. Basta · Boston, MADirectorNichola R. Eliovits · Burlington, MAExec · DirectorMax R. Dawson · Boston, MAExecWilder R. Ramsey · Boston, MADirectorKarl R. Beutner · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗